Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R MAHADEVAN

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Cell Reports. Medicine|November 22, 2023
Aurora A kinase inhibition induces accumulation of SCLC tumor cells in mitosis with restored interferon signaling to increase response to PD-L1Yixiang Li, Navin R Mahadevan, Leslie Duplaquet, et al.
Nature Communications|August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
A cellular and spatial atlas of <i>TP53</i> -associated tissue remodeling in lung adenocarcinomaWilliam Zhao, Benjamin Kepecs, Navin R Mahadevan, et al.
Cancer Research|September 6, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, Maria Saigi, Tetsuo Tani, et al.
Cell Reports. Medicine|June 21, 2025
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platformYuqing Zhang, Zehua Li, Jessica Ritter, et al.
Nature Communications|September 24, 2022
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitorsYoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA ProfilingTalal El Zarif, Catherine B Meador, Xintao Qiu, et al.
Cancer Discovery|January 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor ImmunityTetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Nature Communications|May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancerZehua Li, Cong Fu, Kartik Sehgal, et al.
Nature Cancer|September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypesSatyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Cell Reports. Medicine|November 22, 2023
Aurora A kinase inhibition induces accumulation of SCLC tumor cells in mitosis with restored interferon signaling to increase response to PD-L1Yixiang Li, Navin R Mahadevan, Leslie Duplaquet, et al.
Nature Communications|August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
A cellular and spatial atlas of <i>TP53</i> -associated tissue remodeling in lung adenocarcinomaWilliam Zhao, Benjamin Kepecs, Navin R Mahadevan, et al.
Cancer Research|September 6, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, Maria Saigi, Tetsuo Tani, et al.
Cell Reports. Medicine|June 21, 2025
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platformYuqing Zhang, Zehua Li, Jessica Ritter, et al.
Nature Communications|September 24, 2022
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitorsYoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA ProfilingTalal El Zarif, Catherine B Meador, Xintao Qiu, et al.
Cancer Discovery|January 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor ImmunityTetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Nature Communications|May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancerZehua Li, Cong Fu, Kartik Sehgal, et al.
Nature Cancer|September 22, 2022
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypesSatyaki Sengupta, Sanjukta Das, Angela C Crespo, et al.
Pageof 11